Want to understand your risk for developing Alzheimer's Disease?
This is an exciting time for Alzheimer's research. A number of recent advances are leading to more options, especially progress toward early detection and intervention.

The TRAILBLAZER-ALZ 3 study is a new research study sponsored by Eli Lilly and Company which may help researchers to potentially prevent or slow down the symptoms of Alzheimer's disease.
You can help researchers discover new medications to help alleviate Alzheimer's disease.
NIH Clinical Research Trials and You